DRAVPa2201 |
Sequence 51 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2202 |
Sequence 52 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2203 |
Sequence 53 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2204 |
Sequence 54 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2205 |
Sequence 55 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2206 |
Sequence 56 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2207 |
Sequence 57 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2208 |
AP19 |
Synthetic peptide |
GAstV |
CN115894614A |
DRAVPa2209 |
AP21 |
Synthetic peptide |
GAstV |
CN115894614A |
DRAVPa2210 |
AP30 |
Synthetic peptide |
GAstV |
CN115894614A |
DRAVPa2211 |
Sequence 8 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |
DRAVPa2212 |
Sequence 11 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |
DRAVPa2213 |
Sequence 14 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |
DRAVPa2214 |
Sequence 16 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |
DRAVPa2215 |
Sequence 20 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |
DRAVPa2216 |
Sequence 21 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |
DRAVPa2217 |
Sequence 22 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |
DRAVPa2218 |
Sequence 24 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |
DRAVPa2219 |
Sequence 25 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |
DRAVPa2220 |
Sequence 27 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |